• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质纳米气泡联合超声用于抗瘢痕治疗。

Lipid nano-bubble combined with ultrasound for anti-keloids therapy.

机构信息

a State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.

b Yanbian University Hospital , Yanji , China , and.

出版信息

J Liposome Res. 2018 Mar;28(1):5-13. doi: 10.1080/08982104.2016.1239633. Epub 2016 Nov 23.

DOI:10.1080/08982104.2016.1239633
PMID:27733083
Abstract

Keloids were characterized by excessive growth of fibrous tissues, and shared several pathological characteristics with cancer. They did put physical and emotional stress on patients in that keloids could badly change appearance of patients. N-(4-hydroxyphenyl) retinamide (4HPR) showed cytotoxic activity on a wide variety of invasive-growth cells. Our work was aim to prepare N-(4-hydroxyphenyl) retinamide-loaded lipid microbubbles (4HPR-LM) combined with ultrasound for anti-keloid therapy. 4HPR-loaded liposomes (4HPR-L) were first prepared by film evaporation method, and then 4HPR-LM were manufactured by mixing 4HPR-L and perfluoropentane (PFP) with ultrasonic cavitation method. The mean particle size and entrapment efficiency 4HPR-LM were 113 nm and 95%, respectively. The anti-keloids activity of 4HPR-LM was assessed with BALB/c nude mice bearing subcutaneous xenograft keloids model. 4HPR-LM, combined with ultrasound, could significantly induce apoptosis of keloid fibroblasts in vitro and inhibited growth of keloids in vivo. Thus, 4HPR-LM could be considered as a promising agent for anti-keloids therapy.

摘要

瘢痕疙瘩的特征是纤维组织过度生长,并具有与癌症相似的一些病理特征。它们确实给患者带来了身体和情感上的压力,因为瘢痕疙瘩会严重改变患者的外貌。N-(4-羟基苯基)维甲酸(4HPR)对多种侵袭性生长细胞表现出细胞毒性作用。我们的工作旨在制备载 N-(4-羟基苯基)维甲酸的脂质微泡(4HPR-LM)并结合超声用于抗瘢痕疙瘩治疗。首先采用薄膜蒸发法制备载 4HPR 的脂质体(4HPR-L),然后通过超声空化法将 4HPR-L 和全氟戊烷(PFP)混合制备 4HPR-LM。4HPR-LM 的平均粒径和包封效率分别为 113nm 和 95%。采用 BALB/c 裸鼠皮下移植瘢痕疙瘩模型评估 4HPR-LM 的抗瘢痕疙瘩活性。4HPR-LM 联合超声可显著诱导体外瘢痕疙瘩成纤维细胞凋亡,并抑制体内瘢痕疙瘩生长。因此,4HPR-LM 可被认为是一种有前途的抗瘢痕疙瘩治疗药物。

相似文献

1
Lipid nano-bubble combined with ultrasound for anti-keloids therapy.脂质纳米气泡联合超声用于抗瘢痕治疗。
J Liposome Res. 2018 Mar;28(1):5-13. doi: 10.1080/08982104.2016.1239633. Epub 2016 Nov 23.
2
[Effects of N-(4-hydroxyphenyl) retinamide lipid microbubble combined with ultrasound on human keloid fibroblasts].N-(4-羟基苯基)视黄酸脂质微泡联合超声对人瘢痕疙瘩成纤维细胞的影响
Zhonghua Shao Shang Za Zhi. 2018 Oct 20;34(10):683-689. doi: 10.3760/cma.j.issn.1009-2587.2018.10.007.
3
Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes.通过脂质体负载紫杉醇-胆固醇复合物改善抗瘢痕疙瘩效果。
Int J Nanomedicine. 2019 Feb 21;14:1385-1400. doi: 10.2147/IJN.S195375. eCollection 2019.
4
Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts.聚(L-谷氨酸)共轭的4-(N-羟基苯基)视黄酸酰胺对卵巢癌异种移植瘤的抗肿瘤活性
Gynecol Oncol. 2007 Dec;107(3):441-9. doi: 10.1016/j.ygyno.2007.07.077. Epub 2007 Sep 14.
5
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism.
Blood. 2004 May 1;103(9):3516-20. doi: 10.1182/blood-2003-08-2795. Epub 2003 Dec 24.
6
N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death.N-(4-羟基苯基)视黄酰胺通过活性氧介导的细胞死亡抑制视网膜母细胞瘤生长。
Mol Pharmacol. 2003 Mar;63(3):565-73. doi: 10.1124/mol.63.3.565.
7
The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.转化生长因子-β家族成员骨形态发生蛋白-2和巨噬细胞抑制细胞因子-1作为N-(4-羟基苯基)视黄酰胺抗血管生成活性的介质。
Clin Cancer Res. 2005 Jun 15;11(12):4610-9. doi: 10.1158/1078-0432.CCR-04-2210.
8
Inhibition of Kaposi's sarcoma in vivo by fenretinide.维甲酸对卡波西肉瘤的体内抑制作用。
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6020-9.
9
PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.视黄酸诱导卵巢癌细胞凋亡过程中PLAB的诱导通过一种依赖活性氧的机制发生,该机制涉及内质网应激和JNK激活。
Carcinogenesis. 2009 May;30(5):824-31. doi: 10.1093/carcin/bgp067. Epub 2009 Mar 26.
10
Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo.鉴定雷帕霉素靶蛋白为芬维 A 胺在体内和体外的直接靶标。
Carcinogenesis. 2012 Sep;33(9):1814-21. doi: 10.1093/carcin/bgs234. Epub 2012 Jul 12.

引用本文的文献

1
Low-Frequency Ultrasound Sensitive Piezo1 Channels Regulate Keloid-Related Characteristics of Fibroblasts.低频超声敏感的 Piezo1 通道调节成纤维细胞的瘢痕疙瘩相关特征。
Adv Sci (Weinh). 2024 Apr;11(14):e2305489. doi: 10.1002/advs.202305489. Epub 2024 Feb 4.
2
Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes.通过脂质体负载紫杉醇-胆固醇复合物改善抗瘢痕疙瘩效果。
Int J Nanomedicine. 2019 Feb 21;14:1385-1400. doi: 10.2147/IJN.S195375. eCollection 2019.
3
A comparison of apoptosis levels in keloid tissue, physiological scars and normal skin.
瘢痕疙瘩组织、生理性瘢痕和正常皮肤中细胞凋亡水平的比较。
Am J Transl Res. 2017 Dec 15;9(12):5548-5557. eCollection 2017.